Durata Therapeutics Inc (DRTX) financial statements (2020 and earlier)

Company profile

Business Address 200 SOUTH WACKER DRIVE
CHICAGO, IL 60606
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6045
Cash and cash equivalents3732
Short-term investments2313
Prepaid expense1
Prepaid expense and other current assets6
Income taxes receivable2 
Deferred tax assets01
Other undisclosed current assets1(1)
Total current assets:6351
Noncurrent Assets
Property, plant and equipment11
Intangible assets, net (including goodwill)216
Goodwill66
Intangible assets, net (excluding goodwill)15 
Restricted cash and investments11
Deferred costs0 
Other noncurrent assets4
Other undisclosed noncurrent assets1028
Total noncurrent assets:3735
TOTAL ASSETS:10087
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1622
Accounts payable59
Accrued liabilities711
Employee-related liabilities2 
Taxes payable22
Other undisclosed current liabilities(2) 
Total current liabilities:1422
Noncurrent Liabilities
Long-term debt and lease obligation25 
Long-term debt, excluding current maturities25 
Liabilities, other than long-term debt21
Accrued income taxes11
Other liabilities0 
Other undisclosed noncurrent liabilities2120
Total noncurrent liabilities:4821
Total liabilities:6243
Stockholders' equity
Stockholders' equity attributable to parent, including:3944
Common stock00
Additional paid in capital208151
Other undisclosed stockholders' equity attributable to parent(169)(107)
Total stockholders' equity:3944
TOTAL LIABILITIES AND EQUITY:10087

Income statement (P&L) ($ in millions)

12/31/2013
12/31/2012
Operating expenses(57)(63)
Other operating expense, net(4) 
Other undisclosed operating income4125
Operating income (loss):(57)63
Nonoperating income
(Other Nonoperating income)
1 
Interest and debt expense(2) 
Income (loss) from continuing operations before equity method investments, income taxes:(59)63
Other undisclosed loss from continuing operations before income taxes(2)(0)
Income (loss) from continuing operations before income taxes:(61)63
Income tax expense(1) 
Income (loss) before gain (loss) on sale of properties:(62)63
Other undisclosed net loss (125)
Net loss available to common stockholders, diluted:(62)(63)

Comprehensive Income ($ in millions)

12/31/2013
12/31/2012
Net loss:(62)(63)
Comprehensive loss, net of tax, attributable to parent:(62)(63)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: